Japara Healthcare Limited reported earnings results for the year ended June 30, 2017. For the year, the company reported total revenue of AUD 362,193,000 compared to AUD 327,266,000 for the same period a year ago. EBITDA was AUD 60,160,000 compared to AUD 56,102,000 for the same period a year ago. EBIT was AUD 45,905,000 compared to AUD 44,143,000 for the same period a year ago. NPAT was AUD 29,712,000 compared to AUD 30,375,000 for the same period a year ago. Net cash provided by operating activities was AUD 31,800,000 compared to AUD 36,659,000 for the same period a year ago. Purchase of land & buildings were AUD 7,785,000 compared to AUD 34,259,000 for the same period a year ago. Purchase of plant and equipment were AUD 6,386,000 compared to AUD 5,387,000 for the same period a year ago. Net bank debt as on June 30, 2017 was AUD 19.6 million.

The company provided earnings guidance for the fiscal year 2018 and 2019. Fiscal year 2018 EBITDA expected to be in line with or slightly above fiscal year 2017. EBITDA is expected to increase from fiscal year 2019 as more greenfield developments complete and ACFI indexation increases recommence.